SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-001538
Filing Date
2024-01-05
Accepted
2024-01-05 16:30:13
Documents
15
Period of Report
2024-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191256-8k_aditxtinc.htm   iXBRL 8-K 32866
2 FORM OF AMENDMENT NO. 1 TO JANUARY 2024 SECURED NOTES ea191256ex10-1_aditxtinc.htm EX-10.1 4138
3 FORM OF AMENDMENT NO. 2 TO JANUARY 2024 SECURED NOTES ea191256ex10-2_aditxtinc.htm EX-10.2 7420
4 FORM OF AMENDMENT NO. 1 TO SEPTEMBER 2024 SECURED NOTES ea191256ex10-3_aditxtinc.htm EX-10.3 6034
  Complete submission text file 0001213900-24-001538.txt   230660

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20240102.xsd EX-101.SCH 3009
6 XBRL LABEL FILE adtx-20240102_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE adtx-20240102_pre.xml EX-101.PRE 22355
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191256-8k_aditxtinc_htm.xml XML 3401
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24516650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)